Mallika Ann Ambat, Actelion Pharmaceuticals
Mallika Ann Ambat, Senior Director, Market Research, Actelion Pharmaceuticals
Mallika Ann Ambat is the Director, US Market Research Lead at Actelion. She has over twenty years of hands-on pharmaceutical and bio-tech experience.
She started her career at Pharma companies such as Hoffman-La Roche and Schering-Plough on the East Coast, and most recently worked at bio-tech companies, including Agouron-Pfizer (formerly in San Diego) and Actelion in the Bay Area.
She has extensive market research experience with key stakeholders (HCPs, patients and payors) and has worked in both primary care and specialty markets. At Actelion, she works in Pulmonary Arterial Hypertension, MF-CTCL and Gaucher’s Disease.
In her role at Actelion, she collaborates closely with her sales analytic colleagues to optimize decisions for business development, portfolio planning and new product commercialization.
Mallika earned an MBA degree from St. Joseph’s University in Philadelphia and has a B.S. in Life Sciences.
Leilani Berchesi, Abbott
Leilani Berchesi, Director of Global Market Insights, Abbott’s Diabetes Care
Leilani Berchesi is Director of Global Market Insights at Abbott’s Diabetes Care division. In this role, she generates deep insights about consumers, healthcare professionals, and payors that inform strategic planning, product innovation, and commercial tactics. She has also held roles both at Abbott and at other organizations focusing on strategic planning, analytics, insights generation, and brand marketing. She is passionate about understanding the hidden influences and motivations behind a person’s thoughts, perceptions, and actions and using those to help customers experience life more fully.
Palu Dedhia, Genentech
Palu Dedhia, Market Research Lead, Genentech
Michael Gerhold, Neurocrine Biosciences
Michael Gerhold, Head of Commercial Analytics, Neurocrine Biosciences
Michael is the Head of Commercial Analytics at Neurocrine Biosciences. In his role, Michael oversees a team that provides market research and analytics support for newly launched INGREZZA as well as life cycle management opportunities.
Prior to joining Neurocrine Biosciences, Michael was at Otsuka Pharmaceuticals where he provided market research insights to the successful HCP and DTC launch of Rexulti, a novel antipsychotic. Michael has over 15 years of experience working in a variety of roles in market research, marketing, analytics and forecasting supporting in-line brand teams, life cycle management, and business development.
Michael holds a MBA and Master of Science in Biomedical Engineering from Purdue University and a BS in Biophysics from University of California San Diego. Michael is originally from San Diego, California.
Rahim Hirji, Omeros Corporation
Rahim Hirji, Director, Marketing and New Product Planning, Omeros Corporation
Patrick Hylton, Amgen
Patrick Hylton, Global Marketing Director, Amgen
Carly Loeb, Dermira
Carly Loeb, Ph.D., Sr. Director, Market Insights & Operations, Dermira
Eric Schauble, Gilead Sciences
Eric Schauble, Executive Director, US Commercial Strategic Insights, Gilead Sciences